HSD104 Semaglutide and Tirzepatide in Type 2 Diabetes: Patient Characteristics and Weight-Related Outcomes in the Real-World Setting
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1327
https://www.valueinhealthjournal.com/article/S1098-3015(24)01442-6/fulltext
Title :
HSD104 Semaglutide and Tirzepatide in Type 2 Diabetes: Patient Characteristics and Weight-Related Outcomes in the Real-World Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01442-6&doi=10.1016/j.jval.2024.03.1327
First page :
Section Title :
Open access? :
No
Section Order :
10710